The researchers say that this 39 per cent reduction in seizure prevalence offers powerful evidence the compound may help people living with Dravet syndrome, Which their paper has the primary rigorous scientific data to display this. This is a priority for CBC to create products which are obtainable to all in Canada which include those with visua